Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

MedGenome Stock

Q: How to sell MedGenome stock?

If you hold private company shares of MedGenome - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your MedGenome stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

research.medgenome.comHealthcare / BioTech & PharmaFounded: 2013

MedGenome is a provider of personalized medicine and genomic solutions in immuno-oncology, diabetes, ophthalmology, cardiology and other rare diseases. Additionally, MedGenome's wet lab capabilities have allowed for solutions that enable pharma and biotech companies to accelerate early drug discovery pipelines as well as aid biomarker discoveries for companion diagnostics programs.

Buy or sell MedGenome stockLearn more about MedGenome IPO

OverviewFinancingsValuation

Enterprise Value

Access MedGenome’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like MedGenome.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

MedGenome investors also invested in these private companies

Sequoia Capital

Wiz, xAI, Cerebras, Perplexity, Zipline, Graphcore, Hugging Face, Cohesity, Klarna, Stripe

International Finance Corporation

Bolt, Apeel, Builder.ai, MedGenome, ProducePay, Coursera, Springboard, Mandae

Sofina

Graphcore, Vinted, Cleo, Collibra, Lenskart, MedGenome, Ankorstore, Veepee, Rohlik, Twin Health

Novo Holdings

Tempus, Noom, Octave, Corwave, MedGenome, OnCusp Therapeutics, Nalu, Mission Bio, Hemab Therapeutics, Nalu Medical

LeapFrog Holdings

MedGenome

HDFC

MedGenome

InnoVen Capital

Swiggy, Oyo, Zetwerk, MedGenome

Team

Management Team

Mahesh Pratapneni

Group Chief Executive Officer & Co-Founder, Director

Somasekar Seshagiri

Chief (Genomics and Informatics) & Head (US Operations)

Hiranjith G H

Vice President & Head of Research Services

Dr. V L Ramprasad

Chief Executive Officer - India

Surajit Chakrabartty

Chief Financial Officer

Board Members

Dr. Felix Olale

LeapFrog

Sam Santhosh

Founder

Neeraj Bhargava

Independent Director

Tejeshwi Sharma

Sequoia Capital

MedGenome stock FAQs

Can you buy MedGenome stock?

As MedGenome is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like MedGenome, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy MedGenome stock?

To invest in a private company like MedGenome through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell MedGenome stock?

Yes, you may be able to sell your MedGenome stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell MedGenome stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your MedGenome stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is MedGenome a public company?

No, MedGenome is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is MedGenome’s stock price?

MedGenome is a privately held company and therefore does not have a public stock price. However, you may access MedGenome’s private market stock price with Forge Data.

What is MedGenome’s stock ticker symbol?

MedGenome does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Crunchbase 09/06/2022

MedGenome Raises $50M To Map The Human Genome

Diagnostics and research startup MedGenome announced on Tuesday it raised $50 million led by life science-focused Novo Holdings, bringing total funding to $185.5 million. MedGenome, a California-based startup, leverages genomic sequencing platforms to aid in diagnostics and drug discovery.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.